15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 13.8% per year over the past 5 years.
Net income has grown faster than revenue (110.2% vs 13.8% per year).
Operating margin has expanded, at 52.0% in the latest year.
Financial health
Total debt ($1.5B) exceeds cash ($520M); net debt is $995M.
Total debt has grown slower than revenue (0.8% vs 13.8% per year).
Operating income covered interest expense 5.1× in the latest year, up from 0.9× 5 years ago.
Total debt is 2.6× EBITDA.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 21.7% of earnings.
The dividend has grown 3.9% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$878M
$365M
0.0%
52.0%
17.5%
9.4%
—
$1.5B
$520M
2024
$888M
$320M
0.0%
55.1%
12.7%
6.2%
—
$1.7B
$657M
2023
$848M
$386M
0.0%
70.1%
16.2%
7.3%
—
$2.3B
$711M
2022
$1.1B
$555M
0.0%
59.5%
25.7%
11.3%
—
$2.6B
$718M
2021
$794M
$435M
0.0%
55.6%
25.2%
9.9%
—
$2.4B
$276M
2020
$460M
$9M
0.0%
13.1%
0.7%
0.3%
—
$1.5B
$144M
2019
$478M
$99M
0.0%
36.2%
7.0%
3.3%
—
$1.4B
$149M
2018
$380M
$67M
0.0%
30.8%
5.0%
2.2%
—
$1.3B
$114M
2017
$412M
$73M
0.0%
33.2%
6.0%
2.9%
—
$851M
$179M
2016
$468M
$82M
0.0%
35.5%
7.6%
3.2%
—
$1.1B
$165M
2015
—
$144M
—
—
14.9%
5.5%
—
$1.3B
$100M
2014
—
$115M
—
—
14.3%
4.2%
—
$1.5B
$113M
2013
—
$103M
—
—
15.7%
3.8%
—
$1.9B
$93M
2012
—
$81M
—
—
15.6%
3.5%
—
$1.6B
$267M
2011
—
$88M
—
—
26.5%
4.4%
—
$1.4B
$98M
Valuation over time
How the market has priced CMRE against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 2.0× (Mar '23) to 4.4× (Nov '26).
The price-to-sales ratio has risen from 1.0× (Mar '23) to 1.8× (Nov '26).
The dividend yield has fallen from 10.5% (Mar '23) to 4.9% (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is CMRE growing its revenue and profit?
Over the past 5 years, Costamare Inc.'s revenue has grown 13.8% per year, and net income grown 110.2% per year. These are computed facts, not advice.
How much debt does CMRE have?
As of FY2025, Costamare Inc. reported $1.5B of total debt against $520M of cash; operating income covered interest expense 5.1×.
What is CMRE's profit margin?
In FY2025, gross margin was —, operating margin 52.0%, and net margin 41.5%.
What is CMRE's P/E ratio?
Costamare Inc.'s P/E (TTM) is 4.45 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the CMRE stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 4.4× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.